Dr. Kate Cameron

Dr Kate Cameron CEO & founder of Cytochroma Cytochroma manufactures mini livers that can predict a drug's clinical success in weeks instead of years. Kate pioneered animal free, large scale, liver cell production. She has a PhD from Edinburgh University, has lectured internationally and is a former BBSRC Royal Society of Edinburgh Enterprise Fellow. Kate is a driven entrepreneur and has achieved significant recognition in numerous international business awards, grants, and competitions. Offering faster, more accurate testing in genetically diverse stem cell models, Cytochroma aims to eliminate animal testing and cut the time and cost of drug development to deliver essential medicines faster safer and cheaper.